-
Regeneron to create 400 jobs to support manufacturing in Ireland
pharmaceutical-technology
August 31, 2020
Regeneron Pharmaceuticals has plans to add more than 400 new jobs to its Industrial Operations and Product Supply (IOPS) campus in Limerick, Ireland.
-
Former AstraZeneca UK plant back up for sale, putting 270 jobs at risk
fiercepharma
February 20, 2019
A CDMO that has made a habit of snapping up Big Pharma’s discarded manufacturing plants has put a former AstraZeneca plant into bankruptcy.
-
140 jobs in jeopardy as Recipharm weighs the fate of money-losing plant
fiercepharma
December 20, 2018
A Recipharm plant in the U.K. has been on the edge financially for some time, having been unprofitable for three years. Now, the Swedish-based CDMO says the cost of fixing issues raised by U.K. authorities may be the breaking point.
-
Novartis to cut 2,200 jobs in Switzerland to boost profits
pharmaphorum
September 27, 2018
Novartis has announced that it will cut 2,200 jobs in Switzerland to boost its profitability.
-
Drugmaker GSK to eliminate 650 US jobs
financialexpress
September 07, 2018
The savings from these cuts will help fund increases in research and development and commercial support of new products, Rhyne said
-
Analysis links US government global health R&D funding to jobs, economic benefits across states
worldpharmanews
May 03, 2018
The Trump Administration's proposal to slash funding to fight global health threats like malaria, Ebola, and HIV/AIDS could cost states thousands of jobs and millions of dollars in economic investment and put the health of residents at risk...
-
Takeda to add 70 jobs with €25m Dublin investment
pharmafile
March 02, 2018
Takeda has announced its investment of €25 million to construct a new “modular cell therapy facility dedicated to manufacturing a novel stem cell therapy” at Grange Castle in Dublin will create up to 70 new jobs in the process.
-
Hardin Scientific to Open New Plant, Create 50 Jobs
biospace
January 29, 2018
Officials say a biotech device maker will locate a new manufacturing operation in south-central Kentucky, creating 50 full-time jobs.
-
Novartis to shut down its US generics plant under pricing pressure
pharmafile
October 19, 2017
Novartis has announced that it's going to close its US generics manufacturing plant in Broomfield, Colorado, a change that will resulted in a cut of 450 jobs over two-year long.